Literature DB >> 18317603

Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults.

Mauro Karnikowski1, Cláudio Córdova, Ricardo Jacó de Oliveira, Margô Gomes de Oliveira Karnikowski, Otávio de Tolêdo Nóbrega.   

Abstract

CONTEXT AND
OBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) is a complex clinicopathological entity characterized by diffuse or focal fat accumulation in the hepatic parenchyma of patients who deny abusive alcohol consumption. This study aimed to assess idiopathic NAFLD in community-dwelling, middle-aged and older adults living in the Brazilian Federal District. Associations between NAFLD and components of metabolic syndrome and the whole syndrome were investigated. DESIGN AND SETTINGS: This was a cross-sectional study on 139 subjects aged 55 years or older.
METHODS: NAFLD was diagnosed by means of clinical procedures, to exclude subjects with signs of liver disorders, abusive alcohol consumption and influence from hepatotoxic drugs. Phenotypes were graded based on ultrasound examination. Metabolic syndrome was defined using the NCEP ATP III criteria. Laboratory tests were performed to assist clinical examinations and define the syndrome. RESULTS NAFLD was present in 35.2% of the subjects. Taken together, the two most intense phenotypes correlated with increased serum fasting glucose, triglyceride and VLDL cholesterol levels. Metabolic syndrome was diagnosed in 25.9% of the sample. In addition to associating NAFLD with specific traits of metabolic syndrome, non-parametric analysis confirmed the existence of a relationship (p < 0.05) between the steatotic manifestation and the syndromic condition.
CONCLUSION: Compared with the literature, this study reveals greater frequency of idiopathic NAFLD among Brazilian middle-aged and older adults than is described elsewhere. The findings also suggest that impaired glycemic metabolism coupled with increased fat delivery and/or sustained endogenous biosynthesis is the most likely physiopathogenic mechanisms underlying the onset of NAFLD in this population.

Entities:  

Mesh:

Year:  2007        PMID: 18317603     DOI: 10.1590/s1516-31802007000600006

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  13 in total

1.  Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome.

Authors:  Masahide Hamaguchi; Noriyuki Takeda; Takao Kojima; Akihiro Ohbora; Takahiro Kato; Hiroshi Sarui; Michiaki Fukui; Chisato Nagata; Jun Takeda
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

Review 2.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

Review 3.  Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations.

Authors:  Zaki A Sherif; Armana Saeed; Shima Ghavimi; Seyed-Mehdi Nouraie; Adeyinka O Laiyemo; Hassan Brim; Hassan Ashktorab
Journal:  Dig Dis Sci       Date:  2016-04-01       Impact factor: 3.199

4.  Dietary fat and apolipoprotein genotypes modulate plasma lipoprotein levels in Brazilian elderly women.

Authors:  R S Paula; V C Souza; A L Benedet; E R Souza; J O Toledo; C F Moraes; L Gomes; C S Alho; C Córdova; O T Nóbrega
Journal:  Mol Cell Biochem       Date:  2010-04       Impact factor: 3.396

5.  Osteopontin in bone mineral density of very old Brazilians.

Authors:  Vinícius C Souza; Wladimir M Freitas; Luiz A Quaglia; Simone N Santos; Cláudio Córdova; Andrei C Sposito; Otávio T Nóbrega
Journal:  J Bone Miner Metab       Date:  2013-03-21       Impact factor: 2.626

6.  Tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α.

Authors:  Juliana O Toledo; Clayton F Moraes; Vinícius C Souza; Audrey C Tonet-Furioso; Luís C C Afonso; Cláudio Córdova; Otávio T Nóbrega
Journal:  Clin Interv Aging       Date:  2015-01-09       Impact factor: 4.458

7.  Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Xi-Xi He; Xiao-Li Wu; Ren-Pin Chen; Chao Chen; Xiao-Gang Liu; Bin-Jiao Wu; Zhi-Ming Huang
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

Review 8.  Recent trends in Brazilian medical research. An overview.

Authors:  Mauricio Rocha-e-Silva
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

9.  Prediction of metabolic syndrome by non-alcoholic fatty liver disease in northern urban Han Chinese population: a prospective cohort study.

Authors:  Tao Zhang; Yongyuan Zhang; Chengqi Zhang; Fang Tang; Hongkai Li; Qian Zhang; Haiyan Lin; Shuo Wu; Yanxun Liu; Fuzhong Xue
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

10.  Association between metabolic syndrome and liver histology among NAFLD patients without diabetes.

Authors:  Pushpjeet Kanwar; James E Nelson; Katherine Yates; David E Kleiner; Aynur Unalp-Arida; Kris V Kowdley
Journal:  BMJ Open Gastroenterol       Date:  2016-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.